ask="266.00"
ask_size="200"
average_daily_volume="360234"
bid="20.75"
bid_size="100"
book_value="3.21"
change="+0.26"
change_from_200_day_moving_average="9.34"
change_from_50_day_moving_average="4.52"
change_from_52_week_high="-0.75"
change_From_52_week_low="17.83"
change_in_percent="+1.14%"
close="23.00"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.48"
ebitda="-21.87M"
eps_estimate_current_year="-2.59"
eps_estimate_next_quarter="-0.59"
eps_estimate_next_year="-2.47"
ex_dividend_date="N/A"
float_shares="7129000"
high="23.75"
high_52_weeks="23.75"
last_trade_date="2/15/2017"
last_trade_price="23.00"
last_trade_size="4436"
last_trade_time="4:00pm"
low="22.27"
low_52_weeks="5.17"
market_capitalization="228.92M"
moving_average_200_day="13.66"
moving_average_50_day="18.48"
name="Zynerba Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="30.43"
open="23.10"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+68.32%"
percent_change_from_50_day_moving_average="+24.49%"
percent_change_from_52_week_high="-3.16%"
percent_change_from_52_week_low="+344.87%"
previous_close="22.74"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="7.09"
price_per_sales="4004.16"
revenue="56524.00"
shares_outstanding="9953000"
short_ratio="3.02"
stock_exchange="NGM"
symbol="ZYNE"
volume="747065"
weeks_range_52="5.17 - 23.75"
